Literature DB >> 938991

Intracellular electrophysiological alterations in canine cardiac conducting tissue induced by aprindine and lignocaine.

M I Steinberg, K Greenspan.   

Abstract

The effects of aprindine and lignocaine (lidocaine USP) were compared on intracellularly recorded potentials from normal canine conducting tisues. Only aprindine produced marked depression of the maximum rate of rise (Vmax) of action potentials elicited at normal cycle lengths (1000 ms). Both compounds, however, produced enhanced depression of Vmax at short cycle lengths or at short S1-S2 coupling intervals at normal membrane resting potential. Both lignocaine and aprindine shorten the action potential duration (APD) and effective refractory period (ERP) but increase the EPR/APD ratio. These effects are easily reversible upon perfusion with drug-free solution only in the case of lignocaine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 938991     DOI: 10.1093/cvr/10.2.236

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  12 in total

Review 1.  Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance.

Authors:  S Nattel
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

2.  Aprindine blocks the sodium current in guinea-pig ventricular myocytes.

Authors:  R Sato; I Hisatome; Y Tanaka; N Sasaki; H Kotake; H Mashiba; R Katori
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

Review 3.  [Electrophysiological classification of newer antiarrhythmic drugs (author's transl)].

Authors:  W Schmitz
Journal:  Klin Wochenschr       Date:  1980-09-15

Review 4.  New antiarrhythmic drugs: their place in therapy.

Authors:  D L Keefe; R E Kates; D C Harrison
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

5.  Inhibitory effects of aprindine on the delayed rectifier K+ current and the muscarinic acetylcholine receptor-operated K+ current in guinea-pig atrial cells.

Authors:  Y Ohmoto-Sekine; H Uemura; M Tamagawa; H Nakaya
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

6.  Electrophysiologic actions of aprindine in rabbit atrioventricular node.

Authors:  H Tanaka; M Nishimura; N Homma; Y Habuchi; Y Watanabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-04       Impact factor: 3.000

7.  Evaluation of antagonism of aconitine-induced dysrhythmias in mice as a method of detecting and assessing antidysrhythmic activity.

Authors:  E Winslow
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

8.  Effects on transmembrane action potential, slow inward current and force of contraction in ventricular cardiac muscle of BRL 31660, a new antiarrhythmic drug with class I and class IV activity.

Authors:  R Brückner; W Schmitz; H Scholz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-03       Impact factor: 3.000

9.  Electrophysiological evaluation of the sodium-channel blocker carbamazepine in healthy human subjects.

Authors:  G Kennebäck; L Bergfeldt; T Tomson
Journal:  Cardiovasc Drugs Ther       Date:  1995-10       Impact factor: 3.727

10.  Suppression of refractory arrhythmias by aprindine in patients with the Wolff-Parkinson-White syndrome.

Authors:  P R Reid; H L Greene; P J Varghese
Journal:  Br Heart J       Date:  1977-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.